The additional value of 68 Ga‐PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsy
The Prostate · 2024
DOI: 10.1002/pros.24716 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2024. Verfasst von Joris G Heetman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Sint Antonius Hospital, Utrecht-Nieuwegein, The Netherlands. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Background
Prebiopsy magnetic resonance imaging (MRI) increases the detection rate of clinically significant prostate cancer (csPCa). Prostate‐specific membrane antigen‐positron emission tomography/computed tomography (PSMA PET/CT) maximum standardized uptake value (SUVmax) of the prostate may offer additional value in predicting the likelihood of csPCa in biopsy.
Methods
A single‐center cohort study involving patients with biopsy‐proven PCa who underwent both MRI and PSMA PET/CT between 2020 and 2021. Logistic regression models were developed for International Society of Urological Pathology (ISUP) Grade Group (GG) ≥ 2 and GG ≥ 3 using noninvasive prebiopsy parameters: age, (log‐)prostate‐specific antigen (PSA) density, PI‐RADS 5 lesion presence, extraprostatic extension (EPE) on MRI, and SUVmax of the prostate. Models with and without SUVmax were compared using Likelihood ratio tests and area under the curve (AUC). DeLong's test was used to compare the AUCs.
Results
The study included 386 patients, with 262 (68%) having ISUP GG ≥ 2 and 180 (47%) having ISUP GG ≥ 3. Including SUVmax significantly improved both models' goodness of fit ( p < 0.001). The GG ≥ 2 model had a higher AUC with SUVmax 89.16% (95% confidence interval [CI]: 86.06%–92.26%) than without 87.34% (95% CI: 83.93%–90.76%) ( p = 0.026). Similarly, the GG ≥ 3 model had a higher AUC with SUVmax 82.51% (95% CI: 78.41%–86.6%) than without 79.33% (95% CI: 74.84%–83.83%) ( p = 0.003). The SUVmax inclusion improved the GG ≥ 3 model's calibration at higher probabilities.
Conclusion
SUVmax of the prostate on PSMA PET/CT potentially improves diagnostic accuracy in predicting the likelihood of csPCa in prostate biopsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Sint Antonius Hospital, Utrecht-Nieuwegein, The Netherlands.
- Department of Cardiology, Sint Antonius Hospital, Utrecht-Nieuwegein, The Netherlands.
- Department of Nuclear Medicine, Sint Antonius Hospital, Utrecht-Nieuwegein, The Netherlands.
- Department of Radiology, Sint Antonius Hospital, Utrecht-Nieuwegein, The Netherlands.
- Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.
ORCID-Profile: Joris G Heetman
Zitieren
APA
Heetman, J. G., Paulino Pereira, L. J., Kelder, J. C., Soeterik, T. F. W., Wever, L., Lavalaye, J., van der Hoeven, E. J. R. J., Lam, M. G. E. H., van Melick, H. H. E., & van den Bergh, R. C. N. (2024). The additional value of 68 Ga‐PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsy. The Prostate. https://doi.org/10.1002/pros.24716
Vancouver
Heetman JG, Paulino Pereira LJ, Kelder JC, Soeterik TFW, Wever L, Lavalaye J, et al. The additional value of 68 Ga‐PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsy. The Prostate. 2024. doi:10.1002/pros.24716
BibTeX
@article{Heetman2024,
author = {Heetman, Joris G and Paulino Pereira, Leonor J and Kelder, Johannes C and Soeterik, Timo F W and Wever, Lieke and Lavalaye, Jules and van der Hoeven, Erik J R J and Lam, Marnix G E H and van Melick, Harm H E and van den Bergh, Roderick C N},
title = {The additional value of 68 Ga‐PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsy},
journal = {The Prostate},
year = {2024},
doi = {10.1002/pros.24716}
}
EUVIMED